| Thymoquinone is a potent superoxide anion scavenger OA Badary, RA Taha, AM Gamal El-Din, MH Abdel-Wahab Drug and chemical toxicology 26 (2), 87-98, 2003 | 627 | 2003 |
| The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats OA Badary, AB Abdel-Naim, MH Abdel-Wahab, FMA Hamada Toxicology 143 (3), 219-226, 2000 | 422 | 2000 |
| Thymoquinone protects against carbon tetrachloride hetatotoxicity in mice via an antioxidant mechanism MN Nagi, K Alam, OA Badary, OA Al‐Shabanah, HA Al‐Sawaf, ... IUBMB Life 47 (1), 153-159, 1999 | 363 | 1999 |
| Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity OA Badary, MN Nagi, OA Al-Shabanah, HA Al-Sawaf, MO Al-Sohaibani, ... Canadian journal of physiology and pharmacology 75 (12), 1356-1361, 1997 | 293 | 1997 |
| Naringenin attenuates cisplatin nephrotoxicity in rats OA Badary, S Abdel-Maksoud, WA Ahmed, GH Owieda Life sciences 76 (18), 2125-2135, 2005 | 284 | 2005 |
| A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2 AM Mansour, J Drevs, N Esser, FM Hamada, OA Badary, C Unger, ... Cancer research 63 (14), 4062-4066, 2003 | 274 | 2003 |
| Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice OA Badary Journal of ethnopharmacology 67 (2), 135-142, 1999 | 258 | 1999 |
| Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis. OA Badary, GED AM Cancer detection and prevention 25 (4), 362-368, 2001 | 252 | 2001 |
| Inhibition of benzo (a) pyrene-induced forestomach carcinogenesis in mice by thymoquinone OA Badary, OA Ai-shabanah, MN Nagi, AC AI-Rikabi, MMA Elmazar European Journal of Cancer Prevention 8 (5), 435-440, 1999 | 240 | 1999 |
| Acute and subchronic toxicity of thymoquinone in mice OA Badary, OA Al‐Shabanah, MN Nagi, AM Al‐Bekairi, M Elmazar Drug Development Research 44 (2‐3), 56-61, 1998 | 224 | 1998 |
| Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. OA Al-Shabanah, OA Badary, MN Nagi, NM Al-Gharably, AC Al-Rikabi, ... Journal of experimental & clinical cancer research: CR 17 (2), 193-198, 1998 | 217 | 1998 |
| Cross-sectional study on awareness and knowledge of COVID-19 among senior pharmacy students MS Hamza, OA Badary, MM Elmazar Journal of community health 46, 139-146, 2021 | 144 | 2021 |
| Frequent co-occurrence of the TATA box mutation associated with Gilbert’s syndrome (UGT1A1* 28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6* 2 … C Köhle, B Möhrle, PA Münzel, M Schwab, D Wernet, OA Badary, ... Biochemical pharmacology 65 (9), 1521-1527, 2003 | 125 | 2003 |
| Anticlastogenic activity of thymoquinone against benzo (a) pyrene in mice OA Badary, MF Abd-Ellah, MA El-Mahdy, SA Salama, FM Hamada Food and Chemical Toxicology 45 (1), 88-92, 2007 | 101 | 2007 |
| The protective action of thymol against carbon tetrachloride hepatotoxicity in mice K Alam, MN Nagi, OA Badary, OA Al-Shabanah, AC Al-Rikabi, ... Pharmacological research 40 (2), 159-163, 1999 | 92 | 1999 |
| Ameliorative effects of resveratrol on liver injury in streptozotocin‐induced diabetic rats N Hamadi, A Mansour, MH Hassan, F Khalifi‐Touhami, O Badary Journal of biochemical and molecular toxicology 26 (10), 384-392, 2012 | 88 | 2012 |
| Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling YS Abulfadl, NN El-Maraghy, AAE Ahmed, S Nofal, Y Abdel-Mottaleb, ... Human & experimental toxicology 37 (10), 1092-1104, 2018 | 86 | 2018 |
| In vitro and in vivo effects of ferulic acid on gastrointestinal motility: inhibition of cisplatin-induced delay in gastric emptying in rats OA Badary, AS Awad, MA Sherief, FMA Hamada World Journal of Gastroenterology: WJG 12 (33), 5363, 2006 | 83 | 2006 |
| Protective effect of thymoquinone against carbon tetrachloride-induced hepatotoxicity in mice NM Al-Gharably, OA Badary, MN Nagi, OA Al-Shabanah, HA Al-Sawaf, ... | 80 | 1997 |
| Reducing prescribing errors in the paediatric intensive care unit: an experience from Egypt HZ Alagha, OA Badary, HM Ibrahim, NA Sabri Acta Paediatrica 100 (10), e169-e174, 2011 | 79 | 2011 |
